Natixis Advisors, L.P. Accelerate Diagnostics, Inc Transaction History

Natixis Advisors, L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 27, 2020	SELL	$4.62 - $18.74 $88,080 - $357,278	-19,065 Closed	0 $0
Q2 2019 Aug 12, 2019	SELL	$17.79 - $22.88 $367,576 - $472,746	-20,662 Reduced 52.01%	19,065 $436,000
Q1 2019 May 15, 2019	SELL	$11.76 - $22.15 $964 - $1,816	-82 Reduced 0.21%	39,727 $835,000
Q4 2018 Feb 13, 2019	SELL	$10.42 - $21.94 $346,277 - $729,110	-33,232 Reduced 45.5%	39,809 $457,000
Q3 2018 Nov 13, 2018	SELL	$20.4 - $24.6 $32,864 - $39,630	-1,611 Reduced 2.16%	73,041 $1.68 Million
Q2 2018 Aug 14, 2018	SELL	$19.02 - $24.95 $47,645 - $62,499	-2,505 Reduced 3.25%	74,652 $0
Q1 2018 May 10, 2018	SELL	$22.55 - $29.9 $1.01 Million - $1.34 Million	-44,739 Reduced 36.7%	77,157 $1.76 Million
Q4 2017 Feb 14, 2018	SELL	$18.0 - $30.0 $5,976 - $9,960	-332 Reduced 0.27%	121,896 $3.19 Million
Q3 2017 Nov 14, 2017	BUY	$21.1 - $25.15 $2.58 Million - $3.07 Million	122,228	122,228 $2.74 Million

549K

Ticker AXDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 99,059,904
Market Cap $191M
Description
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

Stay updated on Natixis Advisors, L.P. with notifications on news.